What is William Blair’s Estimate for ELEV Q2 Earnings?
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Analysts at William Blair issued their Q2 2025 earnings estimates for Elevation Oncology in a report issued on Friday, March 7th. William Blair analyst A. Hsieh forecasts that the company will post earnings per share of ($0.21) for the quarter. William Blair has a “Outperform” rating and […]
